For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221010:nRSJ3882Ca&default-theme=true
RNS Number : 3882C Savills PLC 10 October 2022
SAVILLS PLC (THE "COMPANY")
NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS AND CONNECTED PERSONS
The Company announces that it has received notification that Nicholas
Ferguson, Non-Executive Chairman, purchased 10,000 Savills plc ordinary shares
of 2.5p each ("Ordinary Shares") at £8.02244 per share on 10 October 2022.
As a result, Mr Ferguson has a total beneficial interest in 39,286 Ordinary
Shares, representing 0.027% of the Company's issued share capital.
The information set out below is provided in accordance with the requirements
of Article 19 of the EU Market Abuse Regulation No 596/2014.
1. Details of the Director
(a) Name Nicholas Ferguson
2. Reason for the notification
(a) Position/ status Chairman / Non-Executive Director
(b) Initial notification/ Amendment Initial notification
3. Details of the issuer
(a) Name Savills plc
(b) LEI 213800WXICGMBWHTA933
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
(a) Description of the Financial Instrument Savills plc Ordinary Shares of 2.5p each
(b) Identification code of the Financial Instrument GB00B135BJ46
(c) Nature of the transaction Purchase of Ordinary Shares
(d) Price(s) and volume(s) Price(s) Volume(s)
£8.02244 per share 10,000
(e) Aggregated information N/A
- Aggregated volume
- Price
(f) Date(s) of the transactions 10 October 2022
(g) Place of the transaction London Stock Exchange (XLON)
Name of contact and telephone number for queries:
C M Lee
Group Legal Director & Company Secretary
020 3107 5444
10 October 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFZMMGKGKGZZM